Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalDiabetic Medicine
Volume25
Issue number9
Pages (from-to)1129-31
Number of pages3
ISSN0742-3071
DOIs
Publication statusPublished - 1 Sep 2008

ID: 34070364